Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Qritive logo — Qritive makes cancer diagnostics fast, accurate, and afforda...

Qritive

Qritive makes cancer diagnostics fast, accurate, and affordable

Founded 2017 Singapore Singapore 17 employees Non Equity Assistance Total: $9.00M AI, Biotechnology +2

General Information

Company Name Qritive
Founded Year 2017
Location Singapore Singapore +1
Employees 17
Industries AI, Biotechnology, Health Care +1
Funding Stage Non Equity Assistance
Social

Get notified when Qritive moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Qritive

Qritive is a Singapore-based startup that focuses on revolutionizing cancer diagnostics. The company's slogan "Qritive makes cancer diagnostics fast, accurate, and affordable" encapsulates its core mission. Leveraging AI-powered solutions, Qritive aims to enable histopathologic diagnosis of cancer at scale, ultimately delivering faster and more cost-effective results of high accuracy. The company offers a clinical-decision support system for pathologists, enhancing efficiency and quality in diagnosis and consequently leading to better patient outcomes. Qritive's digital pathology platform has garnered attention and adoption from several healthcare institutions in Singapore, India, Morocco, UAE, and the USA. The startup's achievements have been showcased at prestigious events and published in renowned journals, including USCAP 2023, 2022, and 2021, along with a feature in Nature Scientific Report. Founded in 2017, Qritive operates at the intersection of Biotechnology, Health Care, and Information Technology, reflecting its interdisciplinary approach to solving critical medical challenges. The startup recently received a non-equity assistance investment on 29 May 2024, with MedTech Innovator as the contributing investor. With its innovative solutions and successful track record, Qritive stands as a promising player in the biotechnology and healthcare industries, poised to make a significant impact on the future of cancer diagnostics.

Taxonomy: cancer diagnostics, AI-powered solution, microscopy images, patient data analysis, cost-effective diagnostics, automated tools, efficiency in diagnosis, medical imaging, precision medicine, diagnostic accuracy, disease detection

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance •••••• 1
Investor
29 May 2024
Series A •••••• 3
Investor Investor
•••• •••• 		09 Jan 2023
Series A •••••• 1
Investor
01 Jan 2021
Seed Round •••••• 2
Investor Investor
31 Dec 2019
Seed Round •••••• 1 •••• •••• 17 Dec 2018

View All 6 Funding Rounds

Qritive Alternatives & Competitors

Qritive vs
Ibex Medical Analytics
Ibex Medical Analytics United States

Pioneering AI-based cancer diagnostics in pathology

Series C
97 employees
AI, Analytics
Qritive vs
Onward Assist
Onward Assist India

AI platform for Cancer diagnostics | Diagnostic Tools for Histopathologists and Radiologists.

Grant
16 employees
AI, Analytics
Qritive vs
GenerationsE
GenerationsE Canada

Empower Pathologists, Benefit Cancer Patients

Angel
1 employees
Health Care

FAQ About Qritive

Qritive makes cancer diagnostics fast, accurate, and affordable
Qritive was founded in 2017.
Qritive is headquartered in Singapore.
Qritive operates in the following industries: AI, Biotechnology, Health Care, Information Technology.
Qritive has approximately 17 employees.
Qritive has completed 6 funding rounds, raising a total of $9.00M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Qritive include Ibex Medical Analytics, Onward Assist, GenerationsE, Sakura Finetek Europe, Golden Gate Cancer Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Qritive and Ibex Medical Analytics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Qritive and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy